ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

July 9, 2004

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002